![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Drug Discovery Agreement Signed Between
Drug Discovery Agreement Signed Between
May 18, 2005
Leading French pharmaceutical company Fournier Pharma and ComGenex have announced a long-term collaboration for the provision of exclusive chemistry services. The full details of this research collaboration have not been fully disclosed but it is established that ComGenex will provide over a three-year period exclusive chemistry services and will be actually involved in the chemical design of the initial chemical structures, according to Fournier Pharma's indications.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct